This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Japan Science and Technology Agency. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Tetsuhiro Kobayashi: Innovator in Translational Regulation
Introduction
Tetsuhiro Kobayashi is a prominent inventor based in Fukui, Japan. He has made significant contributions to the field of molecular biology, particularly in the area of translational regulation. His innovative work has led to the development of a unique regulatory system that has potential applications in various scientific domains.
Latest Patents
Kobayashi holds a patent for a "Protein-responsive translational regulatory system using RNA-protein interacting motif." The objective of this invention is to provide a translationally regulatable mRNA that can perform specific ON-OFF regulation. This system includes an RNA-protein complex that specifically binds to the mRNA, enhancing its functionality. The invention features an mRNA with an RNA-protein complex interacting motif-derived nucleotide sequence located 5' to the ribosome-binding site or within the 5' region of the open reading frame.
Career Highlights
Tetsuhiro Kobayashi is affiliated with the Japan Science and Technology Agency, where he continues to advance research in translational regulation. His work has garnered attention for its innovative approach to mRNA regulation, which could lead to breakthroughs in gene expression control.
Collaborations
Kobayashi has collaborated with notable colleagues, including Tan Inoue and Hirohide Saito. These partnerships have contributed to the advancement of research in the field and have fostered a collaborative environment for innovation.
Conclusion
Tetsuhiro Kobayashi's contributions to translational regulation exemplify the impact of innovative research in molecular biology. His patented work on RNA-protein interactions showcases the potential for advancements in gene regulation and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
